Researchers found that heart failure patients without insurance were less likely to receive evidence-based beta-blockers, implantable cardioverter-defibrillator or anticoagulation for atrial fibrillation compared to patients with private insurance. The Medicaid group was also less likely to receive the beta-blockers or defibrillators, and Medicare patients were less likely to receive certain beta-blockers. All three groups had longer hospital stays than the private insurance group.
Related Articles on Hospital Cardiology:
Oregon’s Salem Hospital, Five Medical Groups Create Heart & Vascular Institute
Oklahoma State University Medical Center Offers Mobile Cardiology Unit
Florida’s Sacred Heart Health System to Form System-Based Cardiology Group
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
